A novel, mechanism-based approach that addresses the biologic drivers of this progressive disease
Selective APRIL Inhibition and Its Impact on Patient Outcomes in IgA Nephropathy
A novel, mechanism-based approach that addresses the biologic drivers of this progressive disease